F.D.A. Plans to Authorize Pfizer Boosters for All Adults This Weeknews2021-11-17T01:17:59+00:00November 17th, 2021|The New York Times|
Pfizer Asks F.D.A. to Authorize Covid Pill For High-Risk Unvaccinated Peoplenews2021-11-17T00:40:29+00:00November 17th, 2021|The New York Times|
Biden Chooses Robert Califf to Lead F.D.A., Despite Drug Industry Tiesnews2021-11-12T21:31:34+00:00November 12th, 2021|The New York Times|
Democrats Choosing Less Risky Path on Drug Pricesnews2021-11-06T07:00:07+00:00November 6th, 2021|The New York Times|
What Happens Next as F.D.A., C.D.C. Weigh Covid Shots for Childrennews2021-10-26T12:40:51+00:00October 26th, 2021|The New York Times|
F.D.A. to Allow ‘Mix and Match’ Approach for Covid Booster Shotsnews2021-10-18T23:32:29+00:00October 18th, 2021|The New York Times|
Where Things Stand on Boosters for Three Vaccines in the U.S.news2021-10-14T19:36:30+00:00October 14th, 2021|The New York Times|
Pfizer Asks F.D.A. to Authorize Its Covid-19 Vaccine for Children 5 to 11news2021-10-08T00:24:12+00:00October 8th, 2021|The New York Times|
Johnson & Johnson to Seek F.D.A. Authorization for Booster Shotnews2021-10-04T17:16:18+00:00October 4th, 2021|The New York Times|
Phony Diagnoses Hide High Rates of Drugging at Nursing Homesnews2021-09-11T16:37:07+00:00September 11th, 2021|The New York Times|
